Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

BACKGROUND: Patient-reported measures can be used to examine whether drug differences other than clinical efficacy have an impact on outcomes that may be important to patients. Although exenatide and insulin glargine appear to have similar efficacy for treatment of type 2 diabetes, there are several...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Secnik Boye, Kristina, Matza, Louis S, Oglesby, Alan, Malley, Karen, Kim, Sunny, Hayes, Risa P, Brodows, Robert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2006
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1634743/
https://ncbi.nlm.nih.gov/pubmed/17034640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-4-80
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak